• About Us
  • Board of Advisors
  • Contact

MALARIA.com

A Malaria Information and Community Portal

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
Home / Archives for Malaria News

Urgent Action Essential to Protect Malaria Therapies, Says WHO

January 12, 2011 By Malaria.com Leave a Comment

The world risks losing its most potent treatment for malaria unless steps are quickly taken to prevent the development and spread of drug resistant parasites, according to a new action plan released today by WHO and Roll Back Malaria partnership (RBM). The Global plan for artemisinin resistance containment outlines the necessary actions to contain and prevent resistance to artemisinins, … [Read more...]

Filed Under: Malaria News Tagged With: Artemisinin-based Combination Therapies, Bill & Melinda Gates Foundation, Global Malaria Action Plan, Malaria Treatment, Margaret Chan, Roll Back Malaria, World Health Organization (WHO)

WHO’s World Malaria Report Shows Rapid Progress Toward Targets

December 14, 2010 By Malaria.com Leave a Comment

A massive scale-up in malaria control programmes between 2008 and 2010 has resulted in the provision of enough insecticide-treated mosquito nets (ITNs) to protect more than 578 million people at risk of malaria in sub-Saharan Africa. Indoor residual spraying has also protected 75 million people, or 10% of the population at risk in 2009. The World Malaria Report 2010 describes how the drive … [Read more...]

Filed Under: Malaria News Tagged With: Artemisinin-based Combination Therapies, Dr. Margaret Chan, Plasmodium Falciparum, Ray Chambers, Rwanda, Sao Tome and Principe, World Health Organization (WHO), World Malaria Report 2010, Zambia

Against Malaria Foundation

November 3, 2010 By Malaria.com Leave a Comment

Malaria.com recommends the Against Malaria Foundation (AMF) to help raise money and awareness of malaria around the world. 100% of the money received by the foundation buys bed nets at the world's lowest prices, and every donation is linked to a distribution so you can see where your net goes. The Against Malaria Foundation was established in 2004, and in 2005 launched the first "World Swim … [Read more...]

Filed Under: Malaria News Tagged With: Against Malaria Foundation

Evolution of Malaria-Transmitting Mosquitoes

October 21, 2010 By Malaria.com Leave a Comment

Researchers have found that the major malaria-transmitting mosquito species, Anopheles gambiae, is evolving into two separate species with different traits, a development that could both complicate malaria control efforts and potentially require new disease prevention methods. A. gambiae is the most common vector of human malaria in sub-Saharan Africa, where rates of the disease are highest. … [Read more...]

Filed Under: Malaria News Tagged With: Anopheles gambiae, DE Neafsey, Genome Sequence, MKN Lawniczak

Anti-Infective Drugs Market to Reach $66 Billion by 2013, Says Report

October 15, 2010 By Malaria.com Leave a Comment

The anti-infective drugs market will jump to $66 billion by 2013, according to a recently published report. Anti-infective drugs include: anti-viral therapeutics, antibiotics, anti-fungal agents and prophylactic treatments such as vaccines. Six infectious diseases -- pneumonia, tuberculosis, diarrheal diseases, malaria, measles and HIV/AIDS -- account for half of all premature deaths worldwide. … [Read more...]

Filed Under: Malaria News Tagged With: Abraxis Bioscience, Acambis, Achillion, Acute Suppurative Thyroiditis, Adlyfe, Advanced Life Sciences Holdings, Affinium, Akonni Biosystems, Alnylam, Anti-fungal Agents, Anti-Infective Drugs, Anti-viral Therapeutics, Antibiotics, APP, Aquapharm Biodiscovery, Arbor Vita, Arpida, Avexa, Avian Bird Flu, Basilea, Baxter, Biophage Pharma, Blood-Borne Infections, CEL-SCI, Cerexa, Combimatrix, Complicated Skin and Skin Structure Infections, cSSSI, Cubist, Daiichi Sankyo, Diarrhea, Hospira, Idenix, Incyte, Influenza, Lymphadenitis, Malaria, Measles, Medivir, Meiji Holdings, MerLion, Mutabilis, Nanobio, Nanosphere, Nanoviricides, Novabay, Obetech, Optimer, Panacos, Pancreatitis, Paratek, Pharmasset, Pharyngotonsillitis, Pico, Pneumonia, Polymedix, Powdermed, Presidio, Progenics, Prophylactic Treatments, Protez, Reye's Syndrome, Rib-X, Ribomed, Sinusitis, Targanta, Theravance, Trius, Tuberculosis, Urinary Tract Infections, UTI, Vascular Infections, Vertex, Viral Encephalitis, West Nile Virus, X-GEN

Research Leads to Promising Malaria Drug Candidate

September 20, 2010 By Malaria.com Leave a Comment

A chemical that rid mice of malaria-causing parasites after a single oral dose may eventually become a new malaria drug if further tests in animals and people uphold the promise of early findings. The compound, NITD609, was developed by an international team of researchers including Elizabeth A. Winzeler, Ph.D., a grantee of the National Institute of Allergy and Infectious Diseases (NIAID), part … [Read more...]

Filed Under: Malaria News Tagged With: Anthony S. Fauci, artemisinins, Elizabeth A. Winzeler, Genomic Institute of the Novartis Research Foundation, Malaria Drugs, National Institutes of Health, NIH, NITD609, Novartis Institute for Tropical Diseases (NITD), Plasmodium Falciparum, Scripps Research Institute, Thierry T. Diagana

NITD609 Compound May Be Promising Malaria Drug Candidate, Say Researchers

September 3, 2010 By Malaria.com Leave a Comment

A chemical that rid mice of malaria-causing parasites after a single oral dose may eventually become a new malaria drug if further tests in animals and people uphold the promise of early findings. The compound, NITD609, was developed by an international team of researchers. “Although significant progress has been made in controlling malaria, the disease still kills nearly 1 million people every … [Read more...]

Filed Under: Malaria News, Malaria Research Tagged With: Anthony S. Fauci, Artemisinin, Elizabeth A. Winzeler, NITD609, Plasmodium Falciparum, Spiroindolones, Thierry T. Diagana

« Previous Page

Stay Informed

WWARN Corner

About WWARN

The WorldWide Antimalarial Resistance Network (WWARN) generates innovative resources and reliable evidence to inform the malaria community on the factors affecting the efficacy of antimalarial medicines. Learn more…

  • Fighting Malaria Requires Protecting the Effectiveness of Antimalarial Medicines
  • Data Sharing at IDDO
  • Evidence to inform equitable dosing in very young and malnourished children

More WWARN Stories...

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
  • About Us
  • Board of Advisors
  • Contact

Copyright © 2025 Malaria.com · Log in